Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors From December 2022 to January 2025, one MRT ...
The U.S. Food and Drug Administration (FDA) has just published a highly-anticipated draft guidance on the implementation of decentralized clinical trials (DCTs) for drugs, biologics, and medical ...
As cardiac technology continues to advance, medical device developers are working rapidly to bring new implantable cardiovascular devices to market. When preparing for a clinical trial, there are ...
The OCTDI under the Office of the Vice President for Health Sciences serves as a hub interconnecting interdisciplinary clinical trial research collaborations among UB investigators and our regional ...
Study participants for this study were recruited at two National Cancer Institute–designated comprehensive cancer centers (CCCs) from April 8, 2019, to September 19, 2019. Eligible participants were ...
On Tuesday, life sciences company LabCorp announced a new technology platform to help streamline the clinical trial and drug development process. The platform was designed for LabCorp’s drug ...
Recently, China's National Medical Products Administration (“NMPA”) released a new version of the Inspection Points for Clinical Trials of Medical Devices. This new rule replaces two previous versions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results